Fighting the invader: strategies against intracellular bacteria
Frontiers in Pharmacology · 20.08.2026 · 17
DOI: 10.3389/fphar.2026.1904697 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.08.2026. Verfasst von Blanca Lorente-Torres und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biología Molecular, Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), Universidad de León, León, Spain. Die Arbeit nennt 439 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intracellular pathogenic bacteria are often-overlooked agent of chronic, recurrent and difficult-to-treat infections in a context of escalating antimicrobial resistance. By hiding within professional and non-professional phagocytes, adopting dormant or slow-replicative states and rewiring host pathways, these pathogens successfully evade both immune clearance and conventional antibiotic therapy, thus contributing to treatment failure and, potentially, carcinogenesis. Here we synthesise how obligate and facultative intracellular bacteria invade and persist within host cells, and interpret these processes as interconnected, engineerable modules of the host-pathogen interplay. Using Staphylococcus aureus as a paradigm of facultative intracellular persistence across diverse tissues, we highlight how these pathways generate long-lived intracellular reservoirs that are poorly addressed by current drugs. Building on this framework, we discuss emerging strategies that explicitly apply engineering principles and tools to intracellular infections, including AI-assisted discovery of novel anti-infectives, rational design of host-directed therapies acting on host pathways, microbiota-based interventions, RNA-based approaches, drug repurposing and combinatorial regimens. We argue that integrating pathogen- and host-targeted strategies within a design-build-test-learn cycle, supported by computational modelling and careful attention to safety and pharmacokinetics, offers a route to engineer eradication of intracellular reservoirs, extend antibiotic lifespan and accelerate translation of new therapies against multidrug-resistant infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Biología Molecular, Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), Universidad de León, León, Spain.
- Instituto de Investigación Biosanitaria de León (IBIOLEÓN), Universidad de León, León, Spain.
- Departamento de Biología Molecular, Instituto de Biología Molecular, Genómica y Proteómica (INBIOMIC), Universidad de León, León, Spain.
- Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, Spain.
- EXPRELA Group, Centro Interdisciplinar de Química e Bioloxía (CICA), Universidade da Coruña, A Coruña, Spain.
Zitieren
APA
Lorente-Torres, B., Castañera, P., Llano-Verdeja, J., Ferrero, H. Á., Fernández-Martínez, S., Javadimarand, F., Mateos, L. M., Mourenza, Á., & Letek, M. (2026). Fighting the invader: strategies against intracellular bacteria. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1904697
Vancouver
Lorente-Torres B, Castañera P, Llano-Verdeja J, Ferrero HÁ, Fernández-Martínez S, Javadimarand F, et al. Fighting the invader: strategies against intracellular bacteria. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1904697
BibTeX
@article{LorenteTorres2026,
author = {Lorente-Torres, Blanca and Castañera, Pablo and Llano-Verdeja, Jesús and Ferrero, Helena Á and Fernández-Martínez, Sergio and Javadimarand, Farzaneh and Mateos, Luis M and Mourenza, Álvaro and Letek, Michal},
title = {Fighting the invader: strategies against intracellular bacteria},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1904697}
}
EUVIMED